Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Daewoong Pharmaceutical's Long-Acting Niclosamide Shows High Promise Against Upcoming COVID-19 'Twindemic' 2020-10-27 21:00
I-Mab to Present Preclinical Data of TJ210 at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting 2020-10-27 20:05
Alterity commences enrolling Multiple System Atrophy patients in bioMUSE Study 2020-10-27 10:03
GMAX Biopharm gives first does of anti-body drug treating PAH in phase 1B trial 2020-10-26 18:00
111, Inc. Teams Up with Huluwa Pharmaceutical to Explore the New Domain of "Internet + pharmaceutical" 2020-10-16 05:40
111 to be the Omni-channel Drug Commercialization Partner of Xiangxu Pharmaceutical for Traditional Chinese Medicine 2020-10-16 05:35
Gannex Received U.S. IND Approval for Its NASH Drug Candidate ASC42,an FXR Agonist 2020-10-12 08:30
Foresee Pharmaceuticals Announces NDA for CAMCEVI(TM) 42MG Accepted for Review by the FDA 2020-10-09 06:39
I-Mab Receives China CDE Approval to Initiate Phase 3 Clinical Trial of Eftansomatropin in Pediatric Patients with Growth Hormone Deficiency 2020-09-30 20:00
The 11th China (Taizhou) International Medical Expo ended successfully 2020-09-30 19:52
TaiGen Biotechnology Out-Licensed Taigexyn (Nemonoxacin) to Luminarie Canada for Canada, Australia and New Zealand 2020-09-30 15:51
VolitionRx Limited Announces Virtual Capital Markets Day 2020 2020-09-29 20:00
GenScript ProBio Congratulates XLifeSc on FDA Allowance of IND Application for TCR-T Program 2020-09-24 22:00
Samsung Biologics signs strategic partnership with Kanaph Therapeutics to develop treatment for retinal diseases 2020-09-24 08:00
ImmVira Announces US$10 million Strategic Series B Plus Financing with SIIC Capital 2020-09-24 00:09
I-Mab Announces China NMPA Clearance for Phase 1 Clinical Trial of Lemzoparlimab in Relapsed or Refractory Advanced Lymphoma 2020-09-21 20:00
PharmAbcine expands partnership with Samsung Biologics for PMC-403 2020-09-21 20:00
Preparation products of Yiling Pharma approved by FDA for launch in the US market 2020-09-19 19:14
MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer 2020-09-18 04:05
Dr. Steven Yu Joins ChemPartner as Vice President of Regulated Bioanalysis 2020-09-17 23:01
1 120 121 122 123 124 170